Researchers at The Wistar Institute's HIV Cure and Viral Diseases Center have successfully identified a new approach using ...
The following is a summary of “First-in-human evaluation of memory-like NK cells with an IL-15 super-agonist and CTLA-4 ...
Creating cancer therapies based around natural killer cells could offer similar levels of efficacy to CAR-T therapies, but at around one hundredth of the cost. Researchers at MD Anderson Cancer ...
The researchers have developed two therapeutic “cocktails” to stop immune cells from overreacting to allergens. The cocktails inhibit key molecules (called ICOSL, OX40L, and CD30L) that they found ...
The switch from autologous to off-the-shelf products is a key step in taking the modality into the mainstream, driving a surge in allogeneic cell therapy R&D activity. NK (natural killer ...
University of Queensland research using natural killer cells may lead to the first new treatment for a devastating childhood ...
The problematic molecules—ICOSL, OX40L, and CD30L—keep memory T cells in the lungs on high alert. While typically these T cells are beneficial, preserving information about past infections to ...
The researchers have developed two therapeutic "cocktails" to stop immune cells from overreacting to allergens. The cocktails inhibit key molecules (called ICOSL, OX40L, and CD30L) that they found ...
The researchers have developed two therapeutic "cocktails" to stop immune cells from overreacting to allergens. The cocktails inhibit key molecules (called ICOSL, OX40L, and CD30L) that they found ...
Within the immune system, interleukin-15 (IL-15) plays a relevant role by boosting the number of cytotoxic T cells and NK cells, the major drivers of anticancer immune response. Researchers from Sotio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results